MassDevice10h
Boston Scientific finalizes $3.7B acquisition of Axonics
Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).
WBJournal9h
Boston Scientific completes $3.7B purchase of California bowel dysfunction company
Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.
Boston Scientific Closes Acquisition of Axonics, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...
The Portugal News17h
Are you a man over 45? Then celebrate blue November!
If the month of October is dedicated to breast health worldwide, November focuses on raising awareness about men’s ...
Boston Scientific Corporation: Boston Scientific Closes Acquisition of Axonics, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: ...
Get chronic UTIs? Future treatments may add more bacteria to your bladder to beat back harmful microbes
Current methods to deliver bacteria to the bladder are invasive and require repeated catheter insertion. Even when bacteria ...
Urology Care Foundation11h
Learn about Muscle-Invasive Bladder Cancer
Most bladder cancers start in the inside lining of the bladder. Muscle-invasive bladder cancer (MIBC) is cancer found in the ...
MedPage Today7h
Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer
And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...
Five symptoms you should never ignore - expert warns when to see your GP
A new survey has revealed that embarrassment is a significant barrier to seeking medical help for Brits, with nearly half admitting they've avoided it in the past ...